3D Bioprinting technology has transformative power which has been radically shaping growth of medical industry globally. Widening demand-supply gap in organ transplants, application in drug toxicity testing and rising demand for orthopedic implants has been key contributors to growth of global 3D Bioprinting market. The report ?Global 3D Bioprinting Market - Focus on Technology, Application and Materials: Market Outlook 2022? provides an in-depth analysis of GLOBAL 3d Bioprinting market overall as well as major technological sub-segments such as Syringe Extrusion 3D Bioprinting, Inkjet 3D Bioprinting, Laser-Assisted 3D Bioprinting, Magnetic Levitation-based 3D Bioprinting and Valve-based 3D Bioprinting. Market outlook for overall 3D Bioprinting market as well as aforementioned sub-segments has been provided for the period 2017-22.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global 3D Bioprinting market. The report has been segmented as following:-

Market Segmentation
? Technology
? Biocompatible Materials
? Applications

Key Vendors
? Organovo Holdings, Inc.
? CELLINK AB
? EnvisionTEC GmbH
? BioBots, Inc.
? Cyfuse Biomedical K.K.

Bioprinting has potential to revolutionize medical practice due to its exciting prospects of creating living cells and tissue using 3D printing technologies. 3D printing in itself is a disruptive technology and one of the greatest instance of next industrial revolution. Bioprinting has emerged as a powerful tool for building tissue and organ structures for drug discovery and regenerative medicine applications. However, the technology is currently in embryonic stage but is rapidly gaining momentum both in academic and commercial setups.

Bioprinting technology has huge market potential for healthcare segment particularly in organ fabrication. Growth of the market is driven by widening demand-supply gap in organ transplants, application in drug toxicity testing and rising demand for orthopedic implants. However, certain factors such as regulatory hurdles, lack of skilled professionals, high costs and limited choice of biomaterials are hindering growth of the industry.
The report ?Global 3D Bioprinting Market - Focus on Technology, Application and Materials: Market Outlook 2022? provides information on the current scenario, detailed market outlook of the global 3D Bioprinting market with detailed analysis of major technologies such as Syringe Extrusion 3D Bioprinting, Inkjet 3D Bioprinting, Laser-Assisted 3D Bioprinting, Magnetic Levitation-based 3D Bioprinting and Valve-based 3D Bioprinting. Future forecasts of 3D Bioprinting market overall and across various technological sub-segments till 2022 is provided in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global 3D Bioprinting market include Organovo Holdings, Inc., CELLINK AB, EnvisionTEC GmbH, BioBots, Inc. and Cyfuse Biomedical K.K., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global 3D Bioprinting market.